Pharma Stock Roundup: PFE Ends Hemophilia Deal With SGMO & More

Zacks 30minutes ago

AbbVie to Host Full-Year and Fourth-Quarter 2024 Earnings Conference Call

PR Newswire35minutes ago

Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields

Benzinga55minutes ago

Morgan Stanley Maintains AbbVie(ABBV.US) With Buy Rating, Maintains Target Price $224

Futu News19:32 · Ratings

After experiencing a bumper harvest in 2024, the USA ETF may encounter setbacks this year.

The USA Exchange Traded Fund (ETF) received a record inflow of $1.1 trillion in 2024, but entering 2025, rapid growth may face more obstacles.

Zhitong FinanceJan 2 20:49

Drug-Trial Results Could Shake Up Pharma Stocks in 2025. Watch Eli Lilly, Pfizer, and More. -- Barrons.com

Barron'sJan 1 16:30